Analytical Data
-
基因名
inuB
-
简介
The InuB protein plays a key role in promoting the bacterium's ability to metabolize sucrose as a sole carbon source. This protein functions as an integral part of the bacterial metabolic process, allowing it to efficiently utilize sucrose for energy and growth. inuB Protein, Bacillus licheniformis (His) is the recombinant inuB protein, expressed by E. coli , with N-6*His labeled tag.
- Application
-
别名
inuB; Sucrose-6-phosphate hydrolase; Invertase
-
种属
Others
-
表达系统
E. coli
-
标签
N-6*His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
U3M0R8
-
表达区间
M1-K492
-
蛋白长度
Full Length
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The research on InuB recombinant protein is situated at the intersection of protein engineering and therapeutic applications, particularly within the context of infectious diseases. InuB, a protein derived from a specific pathogen, has garnered attention due to its potential role in immune response modulation. Historically, similar proteins have been exploited for vaccine development and as therapeutic agents due to their ability to elicit robust immune responses. The unique structural features of InuB, which allow for effective antigen presentation, make it a promising candidate for further investigation. Recent advances in recombinant DNA technology have facilitated the production of InuB in various expression systems, enhancing yield and purity. This opens new avenues for studying its biochemical properties, interactions with immune cells, and overall functionality in immune modulation. Furthermore, elucidating the mechanisms through which InuB engages with the immune system can provide valuable insights into developing novel vaccines and treatments against specific pathogens. As researchers continue to explore its applications, InuB serves as a focal point for understanding protein-based therapies in the biopharmaceutical landscape.
